Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
Introduction To determine the prevalence, clinical outcomes, and factors associated with hydroxyurea (HU) resistance or intolerance among polycythemia vera (PV) and essential thrombocythemia (ET) patients.Methods This study was a retrospective cohort study including PV and ET patients diagnosed by W...
Main Authors: | Kittitat Chiaranairungrot, Komkrich Kaewpreechawat, Chanwit Sajai, Narueporn Pagowong, Nissa Sukarat, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Lalita Norasetthada, Ekarat Rattarittamrong |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2022.2105582 |
Similar Items
-
Essential Thrombocythemia in a Two-year-old Child, Responsive to Hydroxyurea but Not Aspirin
by: Tariq N. Aladily, et al.
Published: (2017-06-01) -
Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high‐risk essential thrombocythemia
by: Young Hoon Park, et al.
Published: (2023-04-01) -
Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview
by: Mauro Cancian, et al.
Published: (2019-08-01) -
In Vitro Hb Production in Β-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to Hydroxyurea
by: Mohammad Reza MAHDAVI, et al.
Published: (2017-06-01) -
Successful Management of Hydroxyurea-induced Leg Ulcers in Essential Thrombocythemia: Report of 3 Cases
by: Jihane Abou Rahal, et al.
Published: (2013-06-01)